[PAR] YoY Annual Result on 30-Jun-2018 [#FY]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#FY]
Profit Trend
YoY- -44.80%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Annual Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 31/03/15 CAGR
Revenue 21 0 2,984 2,683 1,823 1,291 0 -
PBT -42,646 -15,947 -18,611 -8,873 -6,099 -4,215 -1,565 69.62%
Tax -8,349 -3,648 -2,984 -2,683 -1,823 -1,291 7 -
NP -34,297 -12,299 -15,628 -6,190 -4,275 -2,924 -1,565 63.81%
Tax Rate - - - - - - - -
Total Cost 34,318 12,299 18,611 8,873 6,099 4,215 1,565 63.83%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 31/03/15 CAGR
NP Margin -166,896.27 0.00 -523.73 -230.76 -234.49 -226.60 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 31/03/15 CAGR
EPS -0.16 -0.06 -0.11 -0.05 -0.04 -0.03 -0.05 20.43%
EPS Diluted -0.16 -0.06 -0.11 -0.05 -0.04 -0.03 -0.05 20.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.